Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
142.88B
Market cap142.88B
Price-Earnings ratio
53.07
Price-Earnings ratio53.07
Dividend yield
Dividend yield
Average volume
7.90M
Average volume7.90M
High today
$99.62
High today$99.62
Low today
$96.19
Low today$96.19
Open price
$99.14
Open price$99.14
Volume
5.18M
Volume5.18M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $96.38. The company's market cap stands at 142.88B, with a P/E ratio of 53.07.

During the trading session on 2025-11-19, Boston Scientific(BSX) shares reached a daily high of $99.62 and a low of $96.19. At a current price of $96.38, the stock is +0.2% higher than the low and still -3.3% under the high.

Trading volume for Boston Scientific(BSX) stock has reached 5.18M, versus its average volume of 7.9M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

Nasdaq 3h
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?

The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. Acco...

BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
Simply Wall St 21h
How Investors May Respond To Boston Scientific Securing Exclusive U.S. and Japan Rights for Siemens Catheter

Boston Scientific recently announced a catheter development and commercialization agreement with Siemens Healthineers for the AcuNav 4D intracardiac echocardiog...

How Investors May Respond To Boston Scientific Securing Exclusive U.S. and Japan Rights for Siemens Catheter
Nasdaq 5d
Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

Peter Lynch Detailed Fundamental Analysis - BSX

Analyst ratings

94%

of 36 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

More BSX News

Simply Wall St 7d
Is Boston Scientific’s Recent Regulatory Wins Enough to Support Its Rising Share Price?

Wondering if Boston Scientific is a hidden value pick, an overrated star, or something in between? You are in the right place for a straightforward take on what...

Is Boston Scientific’s Recent Regulatory Wins Enough to Support Its Rising Share Price?

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.